The Best Marijuana Stock to Own for the Next 50 Years

Hexo Corp. (TSX:HEXO)(NYSE:HEXO) is building a cannabis business ready to grow for decades to come.

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The past two years have been a roller coaster ride for marijuana investors. In 2018, cannabis stocks were regularly doubling in price. In 2019, they were regularly halving in the price.

Despite the whirlwind, the pot industry still has a strong decade of growth ahead of it.

Cowen Inc, the leading voice on cannabis stocks, thinks that the U.S. will generate $85 billion in sales by 2030. That’s up from a previous estimate of $80 billion. The firm believes federal legalization in the U.S. should occur by the end of the decade.

In Canada, Cowen believes the market size will eventually approach $5.2 billion. Its previous forecast was $4.8 billion, so Canadian prospects are also on the rise. Notably, the “Cannabis 2.0” phenomenon could add an additional $2.3 billion in near-term sales.

The cannabis bear market of 2019 has created some clear buying opportunities; just be sure to pinpoint stocks that can benefit from U.S. legalization and the rise of Cannabis 2.0 in Canada.

Don’t miss this opportunity

How do you tap the biggest cannabis opportunities to come? It’s simple: don’t do what everybody else is doing.

When cannabis stocks were shooting through the roof in 2018, companies were luring investors with optimistic forecasts for growth. But it wasn’t profit growth.

In reality, companies were simply promising to grow incredible amounts of weed, moving from zero production to 20,000 kilograms of annual capacity in as little as 15 months. Investors were smitten.

But we eventually learned that, like other crops, cannabis would be subject to pricing commoditization. Nearly every company has dealt with falling selling prices, which should only continue as industry supply ramps.

How to do you prevent pricing erosion in a commoditized market? One word: branding. Branding is the reason why Coca-Cola Co can sell you five cents worth of commodities for a dollar. No one else is selling what Coke offers, even if the base ingredients are available anywhere.

Cannabis companies have caught on, and are now attempting to create their own brands from scratch. What percentage of these upstart brands will succeed in having millions of consumers remain loyal to them? Likely not many.

The best way to create a brand that customers know and love is to leverage a brand that customers already know and love. That’s just what Hexo Corp. (TSX:HEXO)(NYSE:HEXO) is doing.

Hexo’s management team realized a long time ago that it couldn’t create billions in market value all on its own. Rather, it focused on building the industry’s first platform.

Hexo now has world-class research and development facilities, massive grow houses, and packaging and distribution capabilities. Any outside company with an existing brand can quickly and efficiently tap into Hexo’s infrastructure to spin-up cannabis products.

Here’s an example. Last year, Hexo worked with Molson Coors Canada Inc. to co-create cannabis drinks. The products should hit shelves this month. What’s more likely to succeed: a Molson-branded cannabis drink or a beverage from an unknown pot start-up? Hexo is betting on the former.

With a $475 million market cap, investors haven’t caught on to how powerful Hexo’s business model is. It’s already attracted Fortune 500 partners, and this year, it plans on closing several more.

It doesn’t matter where these companies are located or what industry they serve, Hexo can deliver on their cannabis needs without requiring them to invest millions of dollars into their own infrastructure.

Which pot stock would I rather own over the next 50 years? The one that can tap literally any cannabis opportunity that presents itself. That’s Hexo Corp.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »